Trials / Completed
CompletedNCT00454350
A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis
A Randomized , Open-Label, Cross-over, Pharmacokinetic Study of Doxercalciferol and Paricalcitol Following Multiple Intravenous Injections in Chronic Kidney Disease Subjects on Hemodialysis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Genzyme, a Sanofi Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will measure serum levels of the active Vitamin D compound that circulates in hemodialysis subjects treated with either doxercalciferol injection (Hectorol®) or Zemplar® (paricalcitol injection).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hectorol (doxercalciferol injection) | |
| DRUG | Zemplar (Paricalcitol injection) |
Timeline
- Start date
- 2007-02-01
- Completion
- 2007-07-01
- First posted
- 2007-03-30
- Last updated
- 2015-05-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00454350. Inclusion in this directory is not an endorsement.